Writing for Medications- Clinical Pearls

Size: px
Start display at page:

Download "Writing for Medications- Clinical Pearls"

Transcription

1 Writing for Medications- Clinical Pearls Dr Pete Antonopoulos PharmD Clinical Pharmacist Specialist Stroger Hospital of Cook County UIC Assistant Clinical Professor

2 Inpatients Prescriptions Cerner PowerChart (Computer Order Entry COE) Exceptions Chemo, TPN, PCA orders Write Legibly (Pt name, signature, DX, ALL) If BSA or weight based dosing (write info)

3 Cerner PowerChart Ordering medications in PowerChart: Quick type first 3 letters Drugs listed by generic names Depakote = Divalproex sodium

4 NARCOTIC C 3-5 DEA number (attendings or if a resident has a perm license) Hand printed signature of MD with DEA C 3-5: = codeine, hydrocodone, alprazolam, phenobarbital, zolpidem, Lomotil (diphenoxylate) and Tramadol Write out quantity in name & number (#fifty (#50))

5 C-2 s The Big Ones Separate Prescription C-2 s only! i.e.morphine goes on a separate prescription sheet Physician s original signature Write quantity (sixty and 60) No refills!!! No faxes!!! No changes!!! (no exceptions) Morphine IR=immediate release Q2-4h Morphine SR= sustained release Q12h Fentanyl patch Q 72 hr

6 Medication Safety 5 Rights

7 Medication Errors Common occurrence and continue to be a problem in the health care industry Annual cost of drug-related morbidity and mortality is nearly $177 billion in the United States Approximately 7,000 deaths occur each year 1 of every 5 doses given in hospitals FDA :at least one death per day and 1.3 million people are injured each year due to medication errors

8 Medication Errors ~ 15% of the medication error occur from illegible handwriting problems with leading and trailing zeros, misinterpreted abbreviations, and incomplete medication orders. NEVER EVENTS GUESSING WEIGHTS, DOSING Allergies Extended Release vs Regular Release

9 ADJUSTMENTS DRUGS ARE METABOLIZED / ELIMINATED EITHER RENALLY OR HEPATICALLY ADJUST FOR EITHER OR BOTH RENAL AND HEPATIC INSUFFICIENCY CROCK-KOFF-GAULT EQUATION MDRD CHILDS-PUGH ELDERLY GENDER NATIONALITY

10 DRUG INTERACTIONS CYTOCHROME P-450 P-GLYCOPROTEINS DRUGS WITH MULTIPLE INTERACTIONS: HIV MEDS, COUMADIN, AMIODARONE, DIGOXIN, ANTIEPILEPTICS, ETC USE LEXICOMP IN UP-TO-DATE AND LOOK AT CERNER POP-UPS

11 Medication safety: Look Alike Sound Alike Drug names can often sound similar or appear similar. The appearance of the products can look similar enough to cause confusion. These can easily be confused contributing to adverse medication events. Stop and Verify spelling, Readback!

12 High Alert Medications The top 5 high-alert medications Insulin Opiates and narcotics Injectable potassium Anticoagulants (heparin, LMWH, warfarin, etc) Sodium chloride solutions above 0.9 percent

13 COMMON ERRORS METOPROLOL / TOPROL _ DAILY INSTEAD: METOPROLOL/TOPROL XL DECIMAL ERRORS COUMADIN 1.0MG GUESSING WEIGHTS WRONG PATIENT WRONG DRUG ANTICOAGULATION INSULIN ALLERGIES

14 Ulcer PROPHYLAXIS NOT NEEDED FOR EVERYONE INTUBATED ICU PATIENTS AND COAGULOPATHY PATIENTS START WITH H-2 BLOCKERS FIRST REMEMBER TO DISCONTINUE UPON DISCHARGE!! Prophylaxis can INCREASE PNEUMONIA RISK ALTERS MEDICATION/NUTRITION ABSORPTION

15 PROTOCOLS ANTICOAGULATION HEPARIN ENOXAPARIN INSULIN MED/SURG ICU ID GUIDELINES CONTRAST INDUCED NEPROPATHY CLOPIDOGREL SKIN BREAKDOWN

16 DVT PROPHYLAXIS DVT RISK ASSESSMENT ON EVERY PATIENT!!! PREFERRED PROPHYLAXIS: HEPARIN 5000 UNITS HEPARIN Q8 HRS (MOD- HIGH RISK) HEPARIN Q8 = ENOXAPARIN 40mg qd HIGH RISK (Intubated, CHF, COPD, MI, STROKE, CANCER, hx DVT/PE, SURGERY, etc) See DVT Guidelines

17 Anticoagulation Enoxaparin Actual bodyweight up to 200 kg 1.5 mg/kg daily for cancer, DVT, small PE Q12 hr dosing for other uses Fondaparinux Actual Body Weight 5-10 mg sc daily Dalteparin Actual Body Weight (100 Units/kg Q12 hr) Coumadin Clinic IRIS referral ph #4-6327

18 Anticoagulation Heparin (Based on IBW) DVT/PE/Bridging Dosing 80 u/kg bolus Max 10,000 units 18 u/kg/hr based on ideal body weight Max 2,000 units/hr initial dose, titrate up or down based on aptt aptt 2-3x baseline (60-90)

19 Contrast Renal Protection SCr 1.1 and above Stop diuretics, metformin Sodium bicarbonate drip in D5W or sterile water if diabetic 3ml/kg bolus over 1 hr before procedure 1ml/kg/hr during procedure and for 6 hr later If patient fluid overloaded check with attending Acetylcysteine 20% for renal protection 1200 mg po with cold juice night before, morning before and 2 doses after procedure separated by 4-6 hrs

20 New Changes Additions Carvedilol Q12hr Isosorbide mononitrate once daily Simvastatin all doses 5-80 mg qhs Amlodipine 5-20mg once daily Equivalence to Nifedipine Nifedipine 30mg = Amlodipine 5 mg Nifedipine 60mg = Amlodipine 10 mg Nifedipine 90mg = Amlodipine 20 mg

21 MAP Medication Assistance Program Helps patient apply for free medication from manufacturers Patients on costly drugs with no insurance See website on-line under Pharmacy in Departments sections (on intranet) List of pharmacies in area with low cost generics Monina Quindipan, PharmD, MAP Coordinator,

22 Services Medication Services available only for Cook County Residents. See list of zip-codes on-line. Non-Cook residents should contact local County Department of Health or MAP Service fee of $3 per medication up to $10 max per visit apply. Currently waived for LOL-H, Medicare, Medicaid If unable to pay patient should go to Finance Department at Room 1290 to apply for LOL-H

23 MEDICATION TIMING COUMADIN DOSED AT BEDTIME STATINS DOSED AT BEDTIME DRUGS THAT HAVE TO BE DOSED Q_HOURLY: ANTIBIOTICS, HEPARIN, ENOXAPARIN, ALL HYPERTENSION DRUGS EXCEPT ISOSORBIDE BID= 9AM/5PM TID= 9AM/1PM/5PM QID= 9AM/1PM/5PM/9PM QD=9AM Calcium before meals to bind Phosphorus Coumadin and NSAIDS, ANTIBIOTICS

24 Intern Survival Guide ID Guidelines on-line Diabetes hospital Guidelines Anticoagulation Guidelines

25 Pharmacy Numbers Inpatient Pharmacy Outpatient Stroger Pharmacy Pharmacy Manager Discharge Pharmacy Clinical On-call Ask for on-call Administrator Fantus Clinic Pharmacy / Pharmacy Manager

26 PHARMACY SERVICES NON-FORMULARY SERVICE PAGER: Inpt Pharmacy Outpt 4-16 PROTOCOLS/GUIDELINES/PAGER: GO TO MAIN CCH WEBPAGE AND UNDER DEPARTMENTS CLICK PHARMACY FORMUALRY PUBLISHED ONLINE ADR (Adverse Drug Reaction) NOT SURE? JUST ASK!!!!

27 Summary 5 rights Outpatient Rx = good handwriting Know Schedule for BID, TID If you are not sure, ASK!

Drug Prescribing. Ravi Menon

Drug Prescribing. Ravi Menon Drug Prescribing Ravi Menon Introduction Approximately 7,000 individual drug doses are administered each day in a 'typical' NHS hospital, 70% of which are prescribed by first year graduates and senior

More information

Clinical Guideline for Anticoagulation in VTE

Clinical Guideline for Anticoagulation in VTE Clinical Guideline for Anticoagulation in VTE These clinical guidelines are intended to provide evidence-based recommendations regarding the anticoagulation in patients with DVT and PE. Please note that

More information

Heparin Drip. Ordering

Heparin Drip. Ordering Heparin Drip Ordering Nurse entering of Heparin drip orders for physicians should only occur in situations when it is not feasible for the physician to enter orders directly Select the Heparin IV Drip

More information

High Alert Medications in the long-term care setting. Carrie Allen PharmD, CGP, BCPS, CCHP

High Alert Medications in the long-term care setting. Carrie Allen PharmD, CGP, BCPS, CCHP High Alert Medications in the long-term care setting Carrie Allen PharmD, CGP, BCPS, CCHP Who does this involve? Nurses Medication aides Pharmacies/pharmacists Medical Records and Data Entry Personnel

More information

WMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT

WMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT WMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT - Entering orders for anticoagulation in Cerner Providers will enter individual orders (oneoffs)

More information

Family Medicine Clinical Pharmacy Forum Vol. 4, Issue 5 (September/October 2008)

Family Medicine Clinical Pharmacy Forum Vol. 4, Issue 5 (September/October 2008) 1 Family Medicine Clinical Pharmacy Forum Vol. 4, Issue 5 (September/October 2008) Family Medicine Clinical Pharmacy Forum is a brief bi-monthly publication from the Family Medicine clinical pharmacists

More information

Ensuring Safety of Anticoagulation Therapy

Ensuring Safety of Anticoagulation Therapy Ensuring Safety of Anticoagulation Therapy Abha Agrawal, MD, FACP Chief Medical Officer Kings County Hospital Clinical Associate Dean SUNY Downstate College of Medicine Brooklyn, NY NYACP Webinar April

More information

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes. Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical

More information

ADULT POST NEUROLOGIC INTERVENTION ORDERS 2 of 4

ADULT POST NEUROLOGIC INTERVENTION ORDERS 2 of 4 9 Actual 9 Estimated DOWNTIME INTERVENTION 1 of 4 Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART Admit to Dr.: Bed Type: Dx: ( ) Check, circle and/or fill in all

More information

Special Situations 1

Special Situations 1 Special Situations 1 Outline Continuous Nutrition Tube feeds TPN Steroids Pumps Perioperative BG Control 2 Patient receiving continuous TF or TPN Continuous nutrition coverage options: Analog q4hr Regular

More information

Pathology Service User Guide Haematology

Pathology Service User Guide Haematology Pathology Service User Guide Haematology St Richard s This section of the Pathology Service User Guide includes: Anticoagulant Therapy Information about the Anticoagulant Clinic Low Molecular Weight Heparin

More information

Is it so small a thing To have enjoy d the sun, To have lived light in the spring, To have loved, to have thought, to have done e133

Is it so small a thing To have enjoy d the sun, To have lived light in the spring, To have loved, to have thought, to have done e133 chapter NINE costs of chronic kidney disease Is it so small a thing To have enjoy d the sun, To have lived light in the spring, To have loved, to have thought, to have done Matthew Arnold, From the Hymn

More information

Estimating Medicaid Costs for Cardiovascular Disease: A Claims-based Approach

Estimating Medicaid Costs for Cardiovascular Disease: A Claims-based Approach Estimating Medicaid Costs for Cardiovascular Disease: A Claims-based Approach Presented by Susan G. Haber, Sc.D 1 ; Boyd H. Gilman, Ph.D. 1 1 RTI International Presented at The 133rd Annual Meeting of

More information

Physician Orders ADULT: PCI Post Procedure Plan

Physician Orders ADULT: PCI Post Procedure Plan Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: PCI Post Procedure Phase, When to Initiate: Initiate Powerplan Phase Phase: Post Cath/PCI Hydration Protocol Phase,

More information

Hip Hemiarthroplasty Post Op Version 2 4/20/17

Hip Hemiarthroplasty Post Op Version 2 4/20/17 Patient Name: Diagnosis: Allergies with reaction type: Hip Hemiarthroplasty Post Op Version 2 4/20/17 Patient Placement General Diagnosis/Procedure: Preferred Location/Unit Ortho/Neuro PCU ICU General

More information

THE QUEEN ELIZABETH HOSPITAL The Do Not Use List aka ISMP s List of Error-Prone Abbreviations, Symbols, and Dose Designations

THE QUEEN ELIZABETH HOSPITAL The Do Not Use List aka ISMP s List of Error-Prone Abbreviations, Symbols, and Dose Designations Abbreviation to be avoided Potential Problem µg Microgram Mistaken for mg (milligrams) resulting in one thousand fold dosing overdose. IU International Mistaken for IV (intravenous) or 10 unit (ten). A.S.,

More information

a. A pharmacist may order a baseline SCr per protocol

a. A pharmacist may order a baseline SCr per protocol UNITYPOINT HEALTH - MARSHALLTOWN Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE Subject: Anticoagulant Therapy Per Practice Protocol (Formerly Anticoagulant therapy #NPSG.03.05.01) Inpatient Warfarin

More information

Incorporated Dosing Guidelines: Intravenous Heparin Therapy Initial Dose

Incorporated Dosing Guidelines: Intravenous Heparin Therapy Initial Dose Intravenous Heparin Therapy Initial Dose (Max Dose) IV Infusion Rate IV Infusion Rate (Max Dose) Lab Tests High Dose 80 units/kg 8,000 units 18 units/kg/hr 1,800 units/hr Intermediate Dose 5,000 units

More information

Venous Thromboembolism National Hospital Inpatient Quality Measures

Venous Thromboembolism National Hospital Inpatient Quality Measures Venous Thromboembolism National Hospital Inpatient Quality Measures Presentation Overview Review venous thromboembolism as a new mandatory measure set Outline measures with exclusions and documentation

More information

Special instructions: Enter both orders in sequence without discontinuing 1st order.

Special instructions: Enter both orders in sequence without discontinuing 1st order. Appendix 1. Test Case Scenario List and Instructions Test Case 1: 1. Enter patient allergy for Lisinopril in test patient s chart. 2. Enter order for Captopril 12.5 mg PO TID. Special instructions: If

More information

Sample. Fractured Hip Post-Operative Orders. Legend < Mandatory fields o Optional fields. Height Allergies: List or o Up to date in electronic system

Sample. Fractured Hip Post-Operative Orders. Legend < Mandatory fields o Optional fields. Height Allergies: List or o Up to date in electronic system Legend Mandatory fields o Optional fields Height Allergies: List or o Up to date in electronic system cm Weight Diagnosis kg Date (yyyy-mon-dd) Time (hh:mm) Anticipated Date Of Discharge (ADOD) o Greater

More information

Myocardial Infarction Order Set

Myocardial Infarction Order Set Myocardial Infarcti Order Set Date Time 1. [ ] Inpatient: [ ] CCU [ ] PCU [ ] ICU 2. Diagnosis: Admit to: Dr. 3. Code Status: [ ] See Completed Code Sheet * ote: o Code verbal order may ly be taken in

More information

Nuts for Neuro and why I hate EMR

Nuts for Neuro and why I hate EMR Nuts for Neuro and why I hate EMR Roberta S Rose, DO private practice in General neurology Staff physician: IRMC and SRMC I have no disclosures, I m just a working stiff Stroke overview: 2018 Guidelines

More information

I. UNIFORM FORMULARY REVIEW PROCESS

I. UNIFORM FORMULARY REVIEW PROCESS DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 United States Code 1074g, as implemented

More information

Conflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations

Conflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations Conflict of Interest Declaration High Risk Medications in the Hospital Pharmacy None to disclose Monika Gil, Pharm.D. Clinical Staff Pharmacist Rush University Medical Center Chicago, IL Learning Objectives

More information

Appendix IV - Prescribing Guidance for Apixaban

Appendix IV - Prescribing Guidance for Apixaban Appendix IV - Prescribing Guidance for Apixaban Patient Factors Dose of Apixaban If your patient has any of the following MAJOR risk factors: Hypersensitivity to the active substance or to any of the excipients

More information

Davis s Drug Guide Scavenger Hunt 15 th Edition

Davis s Drug Guide Scavenger Hunt 15 th Edition Davis s Drug Guide Scavenger Hunt 15 th Edition This handout is designed to assist you in locating information in the Davis s Drug Guide. Take advantage of the many resources in this text!! Locate the

More information

Do Not Use Abbreviations

Do Not Use Abbreviations Do Not Use Abbreviations The Institute for Safe Medication Practice (ISMP) and the Joint Commission (JACHO) have each developed a list of dangerous abbreviations. The list includes abbreviations considered

More information

NEWSLETTER DUE CARE PROGRAM. WINTER 2014 Summer 2015 COMMONLY ASKED QUESTION:

NEWSLETTER DUE CARE PROGRAM. WINTER 2014 Summer 2015 COMMONLY ASKED QUESTION: DUE CARE PROGRAM NEWSLETTER WINTER 2014 Summer 2015 Lisa Sather, RPh DUR Coordinator Mountain-Pacific Quality Health 3404 Cooney Drive Helena, MT 59602 406-457-5818 The DUE CARE PROGRAM, administered by

More information

6 th Floor and 7 East Nurses Guide Intravenous Drip List Approved for RN Administration University of Kentucky Chandler Medical Center

6 th Floor and 7 East Nurses Guide Intravenous Drip List Approved for RN Administration University of Kentucky Chandler Medical Center RATE Abciximab (Reopro) Alteplase (tpa, Activase) All units 6S and 6W ONLY Platelet aggregation inhibitor Thrombolytic agent Bolus: 0.25 mg/kg IV over 5 min Infusion: 0.125 0.9 mg/kg (max 90 mg); 10% of

More information

Heparin-Induced Thrombocytopenia. Steven Baroletti, PharmD., M.B.A., BCPS Brigham and Women s Hospital

Heparin-Induced Thrombocytopenia. Steven Baroletti, PharmD., M.B.A., BCPS Brigham and Women s Hospital Heparin-Induced Thrombocytopenia Steven Baroletti, PharmD., M.B.A., BCPS Brigham and Women s Hospital Heparin-induced thrombocytopenia (HIT) A serious concern associated with thrombosis development following

More information

Hot Topics: Transitions of Care

Hot Topics: Transitions of Care Our quarterly newsletter is a great way to stay up-to-date on emerging clinical information, medication safety issues, and Larkin s Hospital medication policies and procedures. Hot Topics: Transitions

More information

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,

More information

Initials * Page 1 of 6. (place patient label here) Patient Name: Diagnosis: Allergies with reaction type:

Initials * Page 1 of 6. (place patient label here) Patient Name: Diagnosis: Allergies with reaction type: Patient Name: Diagnosis: Allergies with reaction type: Orthopedic Upper Ext Post Op Version 3 4/20/17 Patient Placement General Diagnosis/Procedure: Preferred Location/Unit Ortho/Neuro General Medical

More information

Paediatric Prescribing Pocket Guide September 2014 (Version 1)

Paediatric Prescribing Pocket Guide September 2014 (Version 1) PAGE 1 Paediatric Prescribing Pocket Guide September 2014 (Version 1) In children, the risk of medication errors is often exacerbated by the need for calculations to determine the dose. Prescribing errors

More information

Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2015

Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2015 Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2015 General Principles: There is compelling data in the medical literature to support

More information

* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS:

* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS: 1. Is this a CMS inpatient only procedure? Yes, admit as inpatient, proceed to # 3 No, proceed to # 2 2. Do you expect that the patient s condition will require a hospital stay that will cross two midnights

More information

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1 Welcome Everyone Sign-In Enjoy Breakfast Meet someone new Enter Raffle Pick a team name Please silence phones We start at 8:00am Monitoring, Sick Days, Inpatient Management - Objectives Objectives: Strategies

More information

Physician Orders ADULT: Atrial Fib/Flutter Plan

Physician Orders ADULT: Atrial Fib/Flutter Plan Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: Atrial Fib/Flutter Phase, When to Initiate: Atrial Fib/Flutter Phase Non Categorized Problem: Atrial fibrillation Problem:

More information

Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins

Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins Tameside Hospital NHS Foundation Trust and NHS Tameside and Glossop Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins Version 5.2 Version: 5.2 Authorised by: Joint Medicines

More information

3/19/2012. What is the indication for anticoagulation? Has the patient previously been on warfarin? If so, what % of the time was the INR therapeutic?

3/19/2012. What is the indication for anticoagulation? Has the patient previously been on warfarin? If so, what % of the time was the INR therapeutic? Abigail E. Miller, PharmD, BCPS Clinical Specialist, Cardiology University of North Carolina Hospitals I have no personal financial relationships with the manufacturers of the products to disclose. Boehringer

More information

Unit6. Prescriptions. Speaking:Giving A Prescription. Vocabulary: Common Latin Rx Terms. Articles: A Prescription: Understanding.

Unit6. Prescriptions. Speaking:Giving A Prescription. Vocabulary: Common Latin Rx Terms. Articles: A Prescription: Understanding. Unit6 Prescriptions Grammar: The Future: Will\ Going to Expressing the Future in Time Clauses Using the Present Progressive and Simple Present to Express Future Time Future Progressive Speaking:Giving

More information

Technician Training Tutorial: Dispensing Oral Blood Thinners

Technician Training Tutorial: Dispensing Oral Blood Thinners (Page 1 of 5) Technician Training Tutorial: Dispensing Oral Blood Thinners Warfarin (Coumadin, Jantoven-U.S., others) is an oral anticoagulant blood thinner used to help prevent blood clots that can lead

More information

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)

More information

Pharmacy Partnership to Improve Patient Outcomes

Pharmacy Partnership to Improve Patient Outcomes Pharmacy Partnership to Improve Patient Outcomes Minnesota Rural Health Conference Session 2B Ryan M. Harden, MD MS Kendra Metz, Pharm D Sarah Nelson, MD June 25, 2018 Involved Partners Involved Partners

More information

Admit date (YYYY/MM/DD): Cardiologist On-Call: Diagnosis: Lab Tests. CBC, Electrolytes, Urea, Creatinine, Glucose, INR, PTT, Urinalysis

Admit date (YYYY/MM/DD): Cardiologist On-Call: Diagnosis: Lab Tests. CBC, Electrolytes, Urea, Creatinine, Glucose, INR, PTT, Urinalysis of nurse 1. Admit under ward Attending Physician: Dr. Admit date (YYYY/MM/DD): Cardiologist On-Call: Diagnosis: Lab Tests 2. On admission (if not already performed in Emergency Department or in Coronary

More information

PPP 1. Continuation, modification, and discontinuation of a medication

PPP 1. Continuation, modification, and discontinuation of a medication PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The

More information

Anticoagulation therapy : improving processes. Hilary Merrett and Fiona Gale, CHKS 18 th October 2010

Anticoagulation therapy : improving processes. Hilary Merrett and Fiona Gale, CHKS 18 th October 2010 Anticoagulation therapy : improving processes using risk management tools Hilary Merrett and Fiona Gale, CHKS 18 th October 2010 Risk management tools and anticoagulation therapy The applicable processes

More information

Pharmacotherapy Issues in the Pediatric Population

Pharmacotherapy Issues in the Pediatric Population Pharmacotherapy Issues in the Pediatric Population Continuing Professional Pharmacy Development Dr. Shane Pawluk, PharmD Dr. Andrea Cartwright, PharmD Dr. Maryam Khaja March 26, 2014 Outline Didactic Session

More information

Intrinsic + Common = aptt. Extrinsic + Common = PT. Common Pathway

Intrinsic + Common = aptt. Extrinsic + Common = PT. Common Pathway Anticoagulant Cases 12 11 Intrinsic + Common = aptt 9 8 10 7 4 Extrinsic + Common = PT 5 2 Common Pathway 1 Xa Inhibitors rivaroxaban (Xarelto) apixaban (Eliquis) edoxaban (Savaysa) What is true regarding

More information

Atrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted.

Atrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted. Patient Name: Diagnosis: Allergies with reaction type: Atrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted. Telemetry Medical Telemetry:

More information

PEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.

PEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:. - Phase:. PHYSICIAN S Diagnosis Weight Allergies DETAILS Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert IV to INT when tolerating

More information

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton Dr. Steve Ligertwood Hospitalist Royal Columbian Hospital Regional Department Head-Hospitalist for Fraser Health Authority Project Lead BC Hospitalist VTE Collaborative Clinical Instructor, UBC School

More information

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. Medications Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. What do I need to know about medications after my heart attack? When you

More information

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness

More information

Chapter 1 The Reversing Agents

Chapter 1 The Reversing Agents Available Strategies to Reverse Anticoagulant Medications Michael L. Smith, Pharm. D., BCPS, CACP East Region Pharmacy Clinical Manager Hartford HealthCare Objectives: Describe the pharmacological agents

More information

Change from lovenox to pradaxa

Change from lovenox to pradaxa P ford residence southampton, ny Change from lovenox to pradaxa 14-11-2017 We wanted to put out a friendly reminder that the Ask 3 Teach 3 (A3T3) initiative is indeed full swing. This is an multidisciplinary

More information

2.5 Other Hematology Consult:

2.5 Other Hematology Consult: The Warfarin Order Sheet has been approved by the P & T committee to be implemented by pharmacists. These orders are not used to treat patients with serious hemorrhagic complications. WARFARIN TARGET INR

More information

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

CARDIAC REHABILITATION PROGRAMME:- MEDICATION CARDIAC REHABILITATION PROGRAMME:- MEDICATION AIM OF THIS SESSION Understand the reasons for taking your medications, Discuss the common side effects associated with these medications - knowing when to

More information

Improving Glycemic Control in the Critical Care

Improving Glycemic Control in the Critical Care Improving Glycemic Control in the Critical Care Setting /Hospitalists Outline Review current guidelines Review current glycemic targets DKA Treatment Building a perfect glycemic control protocol Transition

More information

Pharmacy Leadership, Touching all the Bases

Pharmacy Leadership, Touching all the Bases Pharmacy Leadership, Touching all the Bases John Fanikos, R.Ph., M.B.A. Executive Director of Pharmacy Brigham and Women s Hospital November 16 th, 2018 Abu Dhabi, UAE Objectives Review important characteristics

More information

Assessment. Consults & Referrals

Assessment. Consults & Referrals University of Virginia Health System Clinical Pathway: Whipple Enhanced Recovery After () LOS: 4-5 days Date of Origin/Revision: June 29, 2016/September 6, 2017/January 31, 2018 : SAS : : : D1 D2 D 3/

More information

Orthopedic Admission Hip Fracture Version 2 1/25/2017

Orthopedic Admission Hip Fracture Version 2 1/25/2017 Patient Name: Initial each page and Sign/Date/Time last page Diagnosis: Allergies with reaction type: Orthopedic Admission Hip Fracture Version 2 1/25/2017 Patient Placement Patient Status If the physician

More information

News & Views. Antipsychotics on Maryland Medicaid PDL and Coverage of a 30-day Emergency Supply of Atypical Antipsychotics

News & Views. Antipsychotics on Maryland Medicaid PDL and Coverage of a 30-day Emergency Supply of Atypical Antipsychotics Maryland Medicaid Pharmacy Program News & Views February 2011 Maryland Department of Health and Mental Hygiene /Office of Systems, Operations and Pharmacy Antipsychotics on Maryland Medicaid PDL and Coverage

More information

Medication Safety Presentation

Medication Safety Presentation Appendix E Aid 1: Sample Event Poster Medication Safety Presentation Do YOU know your role on the healthcare team? Do YOU know the questions to ask your pharmacist? Do YOU know safe medication practices?

More information

What s new with DOACs? Defining place in therapy for edoxaban &

What s new with DOACs? Defining place in therapy for edoxaban & What s new with DOACs? Defining place in therapy for edoxaban & Use of DOACs in cardioversion Caitlin M. Gibson, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy University of North Texas

More information

EXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS

EXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS EXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS Samuel Z. Goldhaber, MD Director, VTE Research Group Cardiovascular Division Brigham and Women s Hospital Professor of Medicine Harvard Medical

More information

Protocols for the Management of Cardiac Conditions. By Pam Bayles, RN, BSN

Protocols for the Management of Cardiac Conditions. By Pam Bayles, RN, BSN Protocols for the Management of Cardiac Conditions By Pam Bayles, RN, BSN Deaths in Thousands 1,000 800 600 400 200 0 00 10 20 30 40 50 60 70 80 90 00 06 Years Deaths from diseases of the heart (United

More information

Physician/Clinic Collaborative Practice Agreement

Physician/Clinic Collaborative Practice Agreement Physician/Clinic Collaborative Practice Agreement Effective October 1, 2010, Connecticut Senate Bill 428 (PA 10-117) extends to all settings and medical conditions the opportunity for licensed pharmacists

More information

Failure Modes Effects Analysis of Morphine Prescribing

Failure Modes Effects Analysis of Morphine Prescribing Failure Modes Effects Analysis of Morphine Prescribing Hilary Writer MD FRCPC Elaine Wong BScPhm CPSI Patient Safety and Quality Improvement Forum,14 April 2010 Outline Rationale Medication Incidents with

More information

Physician Orders LEB PICU Status Epilepticus Plan. [ ] No known allergies

Physician Orders LEB PICU Status Epilepticus Plan. [ ] No known allergies Height: cm Weight: kg Allergies: [ ] No known allergies [ ] Initiate Powerplan Phase T;N, Phase: LEB PICU Admit Phase Admission/Transfer/Discharge [ ] Admit Patient to Dr. [ ] Admit Status: [ ] Inpatient

More information

PHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List

PHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List Overview The management of outpatient prescription drugs is an integral part of the medical management program to improve the health and well-being of our members. Prescriber and member involvement is

More information

Managing Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc.

Managing Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc. Managing Narcotics on Workers Comp Claims Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc. October 21, 2014 Outline Rationale Scope list drug list Recommended

More information

Counties in the top and bottom two quintiles of both diabetes and obesity, Age-adjusted percentage of adults aged 20 years who are obese, 2007

Counties in the top and bottom two quintiles of both diabetes and obesity, Age-adjusted percentage of adults aged 20 years who are obese, 2007 Impact of Obesity on Medication Dosing John C. Williamson, PharmD, BCPS, AAHIVE Wake Forest University Baptist Medical Center Winston-Salem, NC Objectives Determine what constitutes the various forms of

More information

DEEP VEIN THROMBOSIS (DVT): TREATMENT

DEEP VEIN THROMBOSIS (DVT): TREATMENT DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada

More information

David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care

David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care Geriatrics Clinic- Providence VAMC VA Grand Rounds

More information

Edoxaban for the treatment and prevention of venous thromboembolism (DVT or PE) or stroke prevention in non-valvular AF

Edoxaban for the treatment and prevention of venous thromboembolism (DVT or PE) or stroke prevention in non-valvular AF Edoxaban for the treatment and prevention of venous thromboembolism (DVT or PE) or stroke prevention in non-valvular AF Traffic light classification- Amber 2 specialist initiation / recommendation Information

More information

High alert medicines

High alert medicines High alert medicines Dr Cristín Ryan, Royal College of Surgeons in Ireland Dr Ahmed Awaisu, College of Pharmacy, Qatar University Dr Bridget Javed, College of Pharmacy, Qatar University Dr Wessam El Kassem,

More information

Reducing the risk of patient harm: A focus on opioids

Reducing the risk of patient harm: A focus on opioids Reducing the risk of patient harm: A focus on opioids New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 Disclosure Matthew Fricker, Matthew Grissinger,

More information

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer

More information

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director

More information

Chapter / Section / Drug

Chapter / Section / Drug 2 Cardiovascular System 2.1 Positive inotropic drugs Digoxin Digoxin specific antibody ( DigiFab ) 2.2 Diuretics 2.2.1 Thiazides and related diuretics Indapamide (1 st Line) Bendroflumethiazide Metolazone

More information

Chapter 2 ~ Cardiovascular system

Chapter 2 ~ Cardiovascular system Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection

More information

Refilling a Prescription with No Refills Remaining

Refilling a Prescription with No Refills Remaining ................................................................................................... Refilling a Prescription with No Refills Remaining Pharmacy Technology Solutions May, 2013 Refilling

More information

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center - Phase: Begin Immediately/Emergency Center Weight PHYSICIAN S Allergies Admit/Discharge/Transfer Patient Status Requested Location: MICU, Pt Status: Inpatient (LOS > 2 midnights) Requested Location: 5E

More information

Chapter 2 is a general introduction to the drug administration

Chapter 2 is a general introduction to the drug administration Chapter 2 Safe and Accurate Drug Administration Chapter Overview Chapter 2 is a general introduction to the drug administration process. It introduces the student to the role of the person who administers

More information

Intensive Insulin in the Intensive Care Unit

Intensive Insulin in the Intensive Care Unit TABLE OF CONTENTS Introduction to Intensive Insulin in Adult Critical Care Patients - UIMCC Guideline for Insulin Infusion in Adult ICU Patients - P&T Committee Formulary Action Intensive Insulin in the

More information

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure Tools for Targeting High Risk Patients in Your Practice Joseph Vande Griend, PharmD, BCPS, CGP Assistant Professor, University of Colorado Departments of Clinical Pharmacy and Family Medicine Skaggs School

More information

Utilizing Automated Adverse Event Detection

Utilizing Automated Adverse Event Detection Utilizing Automated Adverse Event Detection David C Stockwell, MD, MBA Executive Director of Improvement Science Medical Director of Patient Safety and Pediatric ICU Children s National Medical Center

More information

Cost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib

Cost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib Atrial Fibrillation: Guideline Directed Treatment Melissa Wendell, FNP-C, MSN Heart Failure - Lead Nurse Practitioner, Aspirus Wausau Hospital and Aspirus Cardiology Cost and Prevalence of A fib 33.5 million

More information

CORLANOR (ivabradine) oral tablet

CORLANOR (ivabradine) oral tablet CORLANOR (ivabradine) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage

More information

Pharmacodynamics. Other Drug Reactions

Pharmacodynamics. Other Drug Reactions Pharmacodynamics Ok. Now the drug has been re-absorbed, and now it is finally where we want it to go. It s going to go to the heart, the eye, or whatever our target organ may be. Now, once we get there,

More information

High Alert Medications: Reducing Patient Harm. Tennessee Center for Patient Safety Regional Meetings 2017 Brian D. Esters, PharmD, CPPS

High Alert Medications: Reducing Patient Harm. Tennessee Center for Patient Safety Regional Meetings 2017 Brian D. Esters, PharmD, CPPS High Alert Medications: Reducing Patient Harm Tennessee Center for Patient Safety Regional Meetings 2017 Brian D. Esters, PharmD, CPPS Learning Objectives Define High-Alert Medications Identify potential

More information

Anticoagulation Therapy in LTC

Anticoagulation Therapy in LTC Anticoagulation Therapy in LTC By: Cynthia Leung, RPh, BScPhm, PharmD. Clinical Consultant Pharmacist MediSystem Pharmacy Jun 11, 2013 Agenda Stroke and Bleeding Risk Assessment Review of Oral Anticoagulation

More information

5/8/2017. Clinical Pharmacy Specialist Division of Kidney Disease and Hypertension

5/8/2017. Clinical Pharmacy Specialist Division of Kidney Disease and Hypertension Clinical Pharmacy Specialist Division of Kidney Disease and Hypertension Clinical Assistant Professor Adjunct Clinical Associate Professor Pharmacy Practice 1 http://ed.ted.com/lessons/how-do-your-kidneys-work-emma-bryce.

More information

-DVT and PE Reduction Strategy in AWR- Can We Win? Luciano Tastaldi, MD

-DVT and PE Reduction Strategy in AWR- Can We Win? Luciano Tastaldi, MD -DVT and PE Reduction Strategy in AWR- Can We Win? Luciano Tastaldi, MD Summary of the Project Objectives Present Numbers Evolution Challenges of Implementation Discuss Future Directions -Problem at CCF-

More information

PLEASE PRINT PLEASE CHECK THE BOX AFTER THE PHONE NUMBER THAT YOU WANT AS YOUR PREFERRED NUMBER

PLEASE PRINT PLEASE CHECK THE BOX AFTER THE PHONE NUMBER THAT YOU WANT AS YOUR PREFERRED NUMBER NORTHERN VIRGINIA CENTER FOR ARTHRITIS PLEASE PRINT PATIENT REGISTRATION Patient s Name: DOB: Sex: Address: PLEASE CHECK THE BOX AFTER THE PHONE NUMBER THAT YOU WANT AS YOUR PREFERRED NUMBER Home#( ) [

More information

Polypharmacy: So Many Drugs, So Little Time. Shannon O. Smith, MD General Internal Medicine Conference

Polypharmacy: So Many Drugs, So Little Time. Shannon O. Smith, MD General Internal Medicine Conference Polypharmacy: So Many Drugs, So Little Time Shannon O. Smith, MD General Internal Medicine Conference Objectives 1. Recognize polypharmacy and what it means to your patients 2. Fix it. Patient Susie Q

More information

Back to Basics: The Basics of Medication Monitoring

Back to Basics: The Basics of Medication Monitoring DIAMOND PHARMACY SERVICES Back to Basics: The Basics of Medication Monitoring Presented by: Dr. Deborah Milito, Pharm. D., CGP. Director of Clinical and Consultant Services Skilled Division Annual Educational

More information

Managing Perioperative Anticoagulation. Edie Shen MD

Managing Perioperative Anticoagulation. Edie Shen MD Managing Perioperative Anticoagulation Edie Shen MD Anticoagulation VKA Warfarin (Coumadin) DOACs Direct Thrombin Inhibitor Dabigatran (Pradaxa) Factor Xa Inhibitor Rivaroxaban(Xarelto) Apixaban(Eliquis)

More information